Search for: "IN RE WYETH" Results 461 - 480 of 702
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Aug 2012, 5:00 am by Steve McConnell
Wyeth-Ayerst Labs., 585 F.3d 361 (6th Cir. 2004), and the bad one (wretched, awful, horrible, etc - we're tempted to unload the thesaurus on this one) is Desiano v. [read post]
25 Feb 2010, 12:15 am
While clients may appreciate knowing what level of service they're paying for, he added that clients may also shy away from hiring the lowest performers. [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Spain:… [read post]
19 May 2009, 1:13 am
The government is seeking financial penalties against New Jersey-based Wyeth of up to three times the amount lost by Medicaid. [read post]
7 Nov 2014, 5:52 am
., 256 F.3d 1013, 1021 (10th Cir. 2001) (wrong to “construe [a treater’s] ‘heeding’ an adequate warning to mean [s/he] would have given the warning”) (applying Oklahoma law); In re Diet Drug Litigation, 895 A.2d 480, 490-91 (N.J. [read post]
31 Jan 2008, 8:20 am
While Gourdine's probably not all that big of a deal now, with the Supreme Court having agreed to decide Wyeth v. [read post]
2 Feb 2010, 7:28 am by Beck, et al.
The other side first argued, after Wyeth v. [read post]
5 Sep 2013, 12:24 pm by Bexis
  Because (as counsel noted) we are interested in preemption issues – even hard ones for our side, which certainly includes preemption in innovator drug cases post-Wyeth v. [read post]
17 Jun 2014, 8:45 am
Medtonic, 518 U.S. 470 (1996) and Wyeth v. [read post]
21 Nov 2010, 5:56 pm by Steve McConnell
Wyeth, 428 F.3d 1317, 1325 (11th Cir. 2005) (applying Alabama law). [read post]
23 May 2019, 9:30 pm by Alana Bevan
Supreme Court ruled that judges rather than juries should determine whether or not pharmaceutical product liability claims may proceed under the “clear evidence” standard established in Wyeth v. [read post]